ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Update

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIBGet Free Report) was the target of a significant decline in short interest during the month of December. As of December 15th, there was short interest totalling 3,900 shares, a decline of 7.1% from the November 30th total of 4,200 shares. Based on an average daily trading volume, of 12,300 shares, the short-interest ratio is currently 0.3 days.

Institutional Trading of ProShares Ultra Nasdaq Biotechnology

An institutional investor recently raised its position in ProShares Ultra Nasdaq Biotechnology stock. Jane Street Group LLC lifted its position in shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIBFree Report) by 8.4% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,803 shares of the exchange traded fund’s stock after buying an additional 374 shares during the quarter. Jane Street Group LLC owned about 0.35% of ProShares Ultra Nasdaq Biotechnology worth $306,000 as of its most recent SEC filing.

ProShares Ultra Nasdaq Biotechnology Stock Up 0.9 %

Shares of BIB stock traded up $0.43 on Wednesday, reaching $50.66. The stock had a trading volume of 5,849 shares, compared to its average volume of 22,066. ProShares Ultra Nasdaq Biotechnology has a 12 month low of $47.19 and a 12 month high of $69.56. The firm’s 50-day moving average is $57.66 and its two-hundred day moving average is $61.55.

ProShares Ultra Nasdaq Biotechnology Increases Dividend

The firm also recently declared a dividend, which was paid on Tuesday, December 31st. Shareholders of record on Monday, December 23rd were given a dividend of $0.3964 per share. The ex-dividend date of this dividend was Monday, December 23rd. This is an increase from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.15.

About ProShares Ultra Nasdaq Biotechnology

(Get Free Report)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.

Read More

Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.